Hepatoprotective potential of vitamin D on liver fibrosis induced in rats by Thioacetamide | ||||
| Biochemistry Letters | ||||
| Articles in Press, Accepted Manuscript, Available Online from 27 April 2024 PDF (1.02 MB) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/blj.2024.272169.1055 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Othman Ali   1; Fatma Amer2; Mahmoud Elrahany3
| ||||
| 1Chemistry department (Biochemistry Division)-Faculty of Science-Minia University-ElMinia-Egypt | ||||
| 2Chemistry Department (Biochemistry Division)-Faclty of Science-Minia University-ElMinia-Egypt | ||||
| 3Professor of Biochemistry, Department of Biochemistry, Faculty of Medicine, Minia University, Dean of Faculty of Pharmacy, Deraya University | ||||
| Abstract | ||||
| Background: Hepatic fibrosis is a serious disease that causes around 1.5 million deaths annually due to cirrhosis and primary liver cancer. It is a pathological process that leads to the liver tissue losing its natural architecture and a severe accumulation of extracellular matrix proteins. Vitamin D3 is a sunlight hormone which promotes proliferation of cells, differentiation, apoptosis, and angiogenesis associated with hepatic parenchyma. Aim of study: Our aim was to determine the potential of vitamin D to inhibit the progression of hepatic fibrosis induced in albino rats. Material & Methods: In a recent study, Thioacetamide was used to induce hepatic fibrosis in a rat model. Randomly, forty albino rats were classified into four identical groups (ten rats per group). These groups were Healthy group, fibrotic group, Prophylactic group with vitamin D and treated group with vitamin D. Biochemical and histological analysis were evaluated. By using ELISA, IL-6, IL-1B, and TNF-α were examined. Results: The results revealed that there was very highly significant decreased (P˂0.0001) in ALT, ALP, AST, Total Bilirubin and Direct Bilirubin levels in groups which treated with vitamin D (G3, G4) compared with fibrotic group (G2), while there was highly significant increase in albumin (p˃0.001) in vitamin D treated group. Liver sections from vitamin D groups showed markedly decreased hepatic lesions. We found a very highly significant effect of vitamin D on IL-6, IL-1B, and TNF-α levels. Conclusion: There are a potential therapeutic value and antifibrotic effects of Vitamin D on hepatic fibrosis in the thioacetamide model. | ||||
| Keywords | ||||
| Liver Fibrosis; Vitamin D; Thioacetamide; IL-6; TNF-α | ||||
|
Statistics Article View: 21 PDF Download: 42 |
||||
